Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
---|---|---|---|---|---|---|---|
ENST00000464938 | NUCKS1-202 | 228 | - | - | - (aa) | - | - |
ENST00000367142 | NUCKS1-201 | 6496 | XM_005245453 | ENSP00000356110 | 243 (aa) | XP_005245510 | Q9H1E3 |
ensgID | Trait | pValue | Pubmed ID |
---|---|---|---|
ENSG00000069275 | Body Mass Index | 9.81987297723474E-5 | 17903300 |
ENSG00000069275 | Glucose | 7.62130884025447E-8 | 17903298 |
ENSG00000069275 | Cystatins | 5.23723394277269E-14 | 17903292 |
ENSG00000069275 | Cystatins | 1.4189891538334E-9 | 17903292 |
ENSG00000069275 | Mental Competency | 2.07832604537519E-15 | 17903295 |
ENSG00000069275 | Prostate-Specific Antigen | 5E-13 | 25434496 |
ENSG00000069275 | Menarche | 2E-8 | 25231870 |
ENSG00000069275 | Parkinson Disease | 7E-8 | 19915575 |
ENSG00000069275 | Electrocardiography | 6E-7 | 24952745 |
ENSG00000069275 | Body Height | 2E-7 | 23449627 |
ENSG00000069275 | Parkinson Disease | 6E-12 | 27182965 |
ENSG00000069275 | Parkinson Disease | 3E-6 | 24842889 |
ENSG00000069275 | Parkinson Disease | 2E-16 | 25064009 |
ENSG00000069275 | dimethylarginine | 5E-6 | 24159190 |
ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
---|---|---|---|---|---|---|---|---|---|
ENSG00000069275 | rs1775154 | 1 | 205727487 | A | QT interval | 24952745 | [0.27-0.63] unit increase | 0.45 | EFO_0004682 |
ENSG00000069275 | rs951366 | 1 | 205716224 | T | Menarche (age at onset) | 25231870 | [0.02-0.04] unit increase | 0.03 | EFO_0004703 |
ENSG00000069275 | rs823094 | 1 | 205720679 | G | Pubertal anthropometrics | 23449627 | [0.03-0.07] unit decrease | 0.05 | EFO_0004339 |
ENSG00000069275 | rs188212039 | 1 | 205743402 | G | Symmetrical dimethylarginine levels | 24159190 | [1.02-2.56] unit increase | 1.792 | EFO_0005418 |
ENSG00000069275 | rs823128 | 1 | 205744250 | A | Parkinson's disease | 19915575 | [NR] | 1.52 | EFO_0002508 |
ENSG00000069275 | rs4951258 | 1 | 205722188 | A | Atrial fibrillation | 30061737 | [1.02-1.05] | 1.04 | EFO_0000275 |
ENSG00000069275 | rs4951261 | 1 | 205748695 | C | Atrial fibrillation | 29892015 | [1.03-1.06] | 1.05 | EFO_0000275 |
ENSG00000069275 | rs951366 | 1 | 205716224 | C | Atrial fibrillation | 29892015 | [1.03-1.06] | 1.05 | EFO_0000275 |
ENSG00000069275 | rs951366 | 1 | 205716224 | T | Free thyroxine concentration | 30367059 | unit increase (discovery) | 0.037 | EFO_0005130 |
ENSG00000069275 | rs10900522 | 1 | 205714939 | ? | Lipid traits (pleiotropy) (HIPO component 1) | 30289880 | EFO_0004574|EFO_0004530|EFO_0004611|EFO_0004612 |
Ensembl ID | Gene Symbol | Coverage | Identiy | Ortholog | Gene Symbol | Coverage | Identiy | Species |
---|---|---|---|---|---|---|---|---|
ENSG00000069275 | NUCKS1 | 100 | 92.181 | ENSMUSG00000026434 | Nucks1 | 100 | 90.947 | Mus_musculus |
Go ID | Go_term | PubmedID | Evidence | Category |
---|---|---|---|---|
GO:0000724 | double-strand break repair via homologous recombination | 26323318. | IMP | Process |
GO:0000785 | chromatin | - | ISS | Component |
GO:0000790 | nuclear chromatin | 26323318. | IDA | Component |
GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | - | IEA | Function |
GO:0001678 | cellular glucose homeostasis | - | ISS | Process |
GO:0003682 | chromatin binding | 26323318. | IDA | Function |
GO:0003690 | double-stranded DNA binding | 26323318. | IDA | Function |
GO:0003697 | single-stranded DNA binding | - | IEA | Function |
GO:0003723 | RNA binding | 22681889. | HDA | Function |
GO:0005634 | nucleus | 11298763.17604136.25116364.26323318. | IDA | Component |
GO:0005730 | nucleolus | - | IDA | Component |
GO:0005737 | cytoplasm | 17604136. | IDA | Component |
GO:0006275 | regulation of DNA replication | 26323318. | IMP | Process |
GO:0006325 | chromatin organization | - | ISS | Process |
GO:0006357 | regulation of transcription by RNA polymerase II | - | IC | Process |
GO:0008134 | transcription factor binding | 25116364. | IPI | Function |
GO:0019046 | release from viral latency | 25116364. | IMP | Process |
GO:0031297 | replication fork processing | 26323318. | IDA | Process |
GO:0035822 | gene conversion | 26323318. | NAS | Process |
GO:0036297 | interstrand cross-link repair | 26323318. | IMP | Process |
GO:0043923 | positive regulation by host of viral transcription | 25116364. | IGI | Process |
GO:0044829 | positive regulation by host of viral genome replication | 25116364. | IMP | Process |
GO:0045944 | positive regulation of transcription by RNA polymerase II | - | IEA | Process |
GO:0046626 | regulation of insulin receptor signaling pathway | - | ISS | Process |
GO:0046628 | positive regulation of insulin receptor signaling pathway | - | IEA | Process |
GO:0060382 | regulation of DNA strand elongation | 26323318. | IMP | Process |
GO:0071481 | cellular response to X-ray | 26323318. | IMP | Process |
GO:1990968 | modulation by host of RNA binding by virus | 25116364. | IMP | Process |
GO:1990969 | modulation by host of viral RNA-binding transcription factor activity | 25116364. | IGI | Process |
Cancer | Chr | Position | Mutation Type | dbSNP | Protein-change | Allele Freq | RBD |
---|---|---|---|---|---|---|---|
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
ESCA | |||||||
HNSC | |||||||
HNSC | |||||||
KIRC | |||||||
LAML | |||||||
LIHC | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
OV | |||||||
OV | |||||||
PCPG | |||||||
READ | |||||||
READ | |||||||
READ | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC |
Cancer | Type | Freq | Q-value |
---|---|---|---|
BLCA | |||
DLBC | |||
KIRC | |||
READ | |||
TGCT | |||
TGCT | |||
THCA |
Cancer | P-value | Q-value |
---|---|---|
KIRC | ||
STAD | ||
SARC | ||
MESO | ||
ACC | ||
UCS | ||
SKCM | ||
KIRP | ||
PAAD | ||
PCPG | ||
KICH | ||
UCEC | ||
LIHC | ||
LGG | ||
THCA | ||
OV |